Anchor] Recently, colorectal cancer patients in their 20s and 30s have been increasing significantly. Reports indicate that ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) and Tecentriq Hybreza ® ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
Burgess has survived colon cancer three times. She represents one of many instances of cancer rates surging in younger people.
A study of 84 patients under 21 found that most had stage III or IV colorectal cancer at diagnosis, while only 20% had a ...
Why are more people in their 20s, 30s and 40s being diagnosed with cancer? An oncologist explains possible risk factors and ...
A change in your bathroom habits does not always mean cancer However persistent bowel or urinary changes can sometimes be warning signs ...
New research has raised alarms about the rising incidence of advanced colorectal cancer among young individuals, emphasizing the need for heightened awareness ...
New research presented at the American Academy of Pediatrics conference has found that colorectal cancer is becoming ...
Colorectal cancer in young people is often diagnosed at an advanced stage, with researchers finding most patients age 21 or ...
When treating patients with colorectal cancer, I often hear them say, "I was diagnosed even though I had no symptoms at all." ...
Prolonged abdominal pain, bloating, diarrhea, or constipation can make many people think they have irritable bowel syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results